Cascade filtration (CF) with the Haemonetics MCS+: a new technical adaptation
CF was introduced in clinical medicine in 1980. Up to now, exclusively two-vein procedures have been carried out with some limitations to expansion of this technique. In this report we describe the very first application of single-needle CF carried out with Haemonetics MCS + apparatus. Twenty proced...
Gespeichert in:
| Veröffentlicht in: | International journal of artificial organs 2001-03, Vol.24 (3), p.164-166 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 166 |
|---|---|
| container_issue | 3 |
| container_start_page | 164 |
| container_title | International journal of artificial organs |
| container_volume | 24 |
| creator | Valbonesi, M Bo, A De Luigi, M C Bruni, R Stura, P Sanfilippo, B Varinelli, I |
| description | CF was introduced in clinical medicine in 1980. Up to now, exclusively two-vein procedures have been carried out with some limitations to expansion of this technique. In this report we describe the very first application of single-needle CF carried out with Haemonetics MCS + apparatus. Twenty procedures were completed without any untoward effect in patients suffering from TTP, post-hepatitic cryoblobulinemia, familial hypercholesterolemia and acute Guillan-Barrè Syndrome. From 1 to 4 sessions were carried out per patient with the expected laboratory and clinical results. The only limit is the procedure time that averages 231 +/- 48 min., approximately 40% longer than two needle procedures. |
| doi_str_mv | 10.1177/039139880102400309 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77064545</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77064545</sourcerecordid><originalsourceid>FETCH-LOGICAL-c299t-5b4a0b37dc4f61e39024e10923a50960ffe988140852dd5a87e4b3150cfb15c13</originalsourceid><addsrcrecordid>eNplkE1Lw0AURQdRbK3-ARcyK1Ek-l5mJsl0J8FaocWFug6TyQuN5KNmphT_vaktuHB1N-deLoexS4R7xDh-AKFR6CQBhFACCNBHbIxxKIMIJByz8Q4IdsSInTn3CYCRlOqUjRAFygRxzJapcdYUxMuq9r3xVdfym3R2y7eVX3G_Ij431HQt-co6vkzf7qbc8Ja23JNdtZU1NTeFWfvf6jk7KU3t6OKQE_Yxe3pP58Hi9fklfVwENtTaByqXBnIRF1aWEZLQw39C0KEwCnQEZUnDaZSQqLAolElikrlABbbMUVkUE3a931333deGnM-aylmqa9NSt3FZHEMklVQDGO5B23fO9VRm675qTP-dIWQ7idl_iUPp6rC-yRsq_ioHa-IH_Cdpzw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77064545</pqid></control><display><type>article</type><title>Cascade filtration (CF) with the Haemonetics MCS+: a new technical adaptation</title><source>MEDLINE</source><source>SAGE Complete</source><creator>Valbonesi, M ; Bo, A ; De Luigi, M C ; Bruni, R ; Stura, P ; Sanfilippo, B ; Varinelli, I</creator><creatorcontrib>Valbonesi, M ; Bo, A ; De Luigi, M C ; Bruni, R ; Stura, P ; Sanfilippo, B ; Varinelli, I</creatorcontrib><description>CF was introduced in clinical medicine in 1980. Up to now, exclusively two-vein procedures have been carried out with some limitations to expansion of this technique. In this report we describe the very first application of single-needle CF carried out with Haemonetics MCS + apparatus. Twenty procedures were completed without any untoward effect in patients suffering from TTP, post-hepatitic cryoblobulinemia, familial hypercholesterolemia and acute Guillan-Barrè Syndrome. From 1 to 4 sessions were carried out per patient with the expected laboratory and clinical results. The only limit is the procedure time that averages 231 +/- 48 min., approximately 40% longer than two needle procedures.</description><identifier>ISSN: 0391-3988</identifier><identifier>EISSN: 1724-6040</identifier><identifier>DOI: 10.1177/039139880102400309</identifier><identifier>PMID: 11314811</identifier><language>eng</language><publisher>United States</publisher><subject>Cryoglobulinemia - therapy ; Equipment Design ; Female ; Filtration ; Guillain-Barre Syndrome - therapy ; Humans ; Hyperlipoproteinemia Type II - therapy ; Male ; Middle Aged ; Plasmapheresis - instrumentation ; Plasmapheresis - methods ; Purpura, Thrombotic Thrombocytopenic - therapy ; Treatment Outcome</subject><ispartof>International journal of artificial organs, 2001-03, Vol.24 (3), p.164-166</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c299t-5b4a0b37dc4f61e39024e10923a50960ffe988140852dd5a87e4b3150cfb15c13</citedby><cites>FETCH-LOGICAL-c299t-5b4a0b37dc4f61e39024e10923a50960ffe988140852dd5a87e4b3150cfb15c13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11314811$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Valbonesi, M</creatorcontrib><creatorcontrib>Bo, A</creatorcontrib><creatorcontrib>De Luigi, M C</creatorcontrib><creatorcontrib>Bruni, R</creatorcontrib><creatorcontrib>Stura, P</creatorcontrib><creatorcontrib>Sanfilippo, B</creatorcontrib><creatorcontrib>Varinelli, I</creatorcontrib><title>Cascade filtration (CF) with the Haemonetics MCS+: a new technical adaptation</title><title>International journal of artificial organs</title><addtitle>Int J Artif Organs</addtitle><description>CF was introduced in clinical medicine in 1980. Up to now, exclusively two-vein procedures have been carried out with some limitations to expansion of this technique. In this report we describe the very first application of single-needle CF carried out with Haemonetics MCS + apparatus. Twenty procedures were completed without any untoward effect in patients suffering from TTP, post-hepatitic cryoblobulinemia, familial hypercholesterolemia and acute Guillan-Barrè Syndrome. From 1 to 4 sessions were carried out per patient with the expected laboratory and clinical results. The only limit is the procedure time that averages 231 +/- 48 min., approximately 40% longer than two needle procedures.</description><subject>Cryoglobulinemia - therapy</subject><subject>Equipment Design</subject><subject>Female</subject><subject>Filtration</subject><subject>Guillain-Barre Syndrome - therapy</subject><subject>Humans</subject><subject>Hyperlipoproteinemia Type II - therapy</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Plasmapheresis - instrumentation</subject><subject>Plasmapheresis - methods</subject><subject>Purpura, Thrombotic Thrombocytopenic - therapy</subject><subject>Treatment Outcome</subject><issn>0391-3988</issn><issn>1724-6040</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkE1Lw0AURQdRbK3-ARcyK1Ek-l5mJsl0J8FaocWFug6TyQuN5KNmphT_vaktuHB1N-deLoexS4R7xDh-AKFR6CQBhFACCNBHbIxxKIMIJByz8Q4IdsSInTn3CYCRlOqUjRAFygRxzJapcdYUxMuq9r3xVdfym3R2y7eVX3G_Ij431HQt-co6vkzf7qbc8Ja23JNdtZU1NTeFWfvf6jk7KU3t6OKQE_Yxe3pP58Hi9fklfVwENtTaByqXBnIRF1aWEZLQw39C0KEwCnQEZUnDaZSQqLAolElikrlABbbMUVkUE3a931333deGnM-aylmqa9NSt3FZHEMklVQDGO5B23fO9VRm675qTP-dIWQ7idl_iUPp6rC-yRsq_ioHa-IH_Cdpzw</recordid><startdate>20010301</startdate><enddate>20010301</enddate><creator>Valbonesi, M</creator><creator>Bo, A</creator><creator>De Luigi, M C</creator><creator>Bruni, R</creator><creator>Stura, P</creator><creator>Sanfilippo, B</creator><creator>Varinelli, I</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010301</creationdate><title>Cascade filtration (CF) with the Haemonetics MCS+: a new technical adaptation</title><author>Valbonesi, M ; Bo, A ; De Luigi, M C ; Bruni, R ; Stura, P ; Sanfilippo, B ; Varinelli, I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c299t-5b4a0b37dc4f61e39024e10923a50960ffe988140852dd5a87e4b3150cfb15c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Cryoglobulinemia - therapy</topic><topic>Equipment Design</topic><topic>Female</topic><topic>Filtration</topic><topic>Guillain-Barre Syndrome - therapy</topic><topic>Humans</topic><topic>Hyperlipoproteinemia Type II - therapy</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Plasmapheresis - instrumentation</topic><topic>Plasmapheresis - methods</topic><topic>Purpura, Thrombotic Thrombocytopenic - therapy</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Valbonesi, M</creatorcontrib><creatorcontrib>Bo, A</creatorcontrib><creatorcontrib>De Luigi, M C</creatorcontrib><creatorcontrib>Bruni, R</creatorcontrib><creatorcontrib>Stura, P</creatorcontrib><creatorcontrib>Sanfilippo, B</creatorcontrib><creatorcontrib>Varinelli, I</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of artificial organs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Valbonesi, M</au><au>Bo, A</au><au>De Luigi, M C</au><au>Bruni, R</au><au>Stura, P</au><au>Sanfilippo, B</au><au>Varinelli, I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cascade filtration (CF) with the Haemonetics MCS+: a new technical adaptation</atitle><jtitle>International journal of artificial organs</jtitle><addtitle>Int J Artif Organs</addtitle><date>2001-03-01</date><risdate>2001</risdate><volume>24</volume><issue>3</issue><spage>164</spage><epage>166</epage><pages>164-166</pages><issn>0391-3988</issn><eissn>1724-6040</eissn><abstract>CF was introduced in clinical medicine in 1980. Up to now, exclusively two-vein procedures have been carried out with some limitations to expansion of this technique. In this report we describe the very first application of single-needle CF carried out with Haemonetics MCS + apparatus. Twenty procedures were completed without any untoward effect in patients suffering from TTP, post-hepatitic cryoblobulinemia, familial hypercholesterolemia and acute Guillan-Barrè Syndrome. From 1 to 4 sessions were carried out per patient with the expected laboratory and clinical results. The only limit is the procedure time that averages 231 +/- 48 min., approximately 40% longer than two needle procedures.</abstract><cop>United States</cop><pmid>11314811</pmid><doi>10.1177/039139880102400309</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0391-3988 |
| ispartof | International journal of artificial organs, 2001-03, Vol.24 (3), p.164-166 |
| issn | 0391-3988 1724-6040 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_77064545 |
| source | MEDLINE; SAGE Complete |
| subjects | Cryoglobulinemia - therapy Equipment Design Female Filtration Guillain-Barre Syndrome - therapy Humans Hyperlipoproteinemia Type II - therapy Male Middle Aged Plasmapheresis - instrumentation Plasmapheresis - methods Purpura, Thrombotic Thrombocytopenic - therapy Treatment Outcome |
| title | Cascade filtration (CF) with the Haemonetics MCS+: a new technical adaptation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T09%3A17%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cascade%20filtration%20(CF)%20with%20the%20Haemonetics%20MCS+:%20a%20new%20technical%20adaptation&rft.jtitle=International%20journal%20of%20artificial%20organs&rft.au=Valbonesi,%20M&rft.date=2001-03-01&rft.volume=24&rft.issue=3&rft.spage=164&rft.epage=166&rft.pages=164-166&rft.issn=0391-3988&rft.eissn=1724-6040&rft_id=info:doi/10.1177/039139880102400309&rft_dat=%3Cproquest_cross%3E77064545%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77064545&rft_id=info:pmid/11314811&rfr_iscdi=true |